HomeBusinessHealthcare Industry Stock NewsKenvue (KVUE): A Johnson & Johnson (JNJ) Spinoff, Gains On IPO

Kenvue (KVUE): A Johnson & Johnson (JNJ) Spinoff, Gains On IPO

Kenvue (KVUE) gains over 17% fresh off their NYSE debut. Jenny Horne discusses this as KVUE is the consumer health business spin off of Johnson & Johnson (JNJ). KVUE started trading at $25.35, which is up 16% from the IPO price. She talks about how JNJ owns 1.72B KVUE shares. Tune in to find out more about the stock market today.

Market On Close

04 May 2023

ON AIR
12:00 pm
Next Gen Investing
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
ON AIR
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US